
Advancing T2DM Management with Fixed Ratio Combination Therapy – CME by Sanofi
Advancing T2DM Management with Fixed Ratio Combination Therapy at CME by Sanofi, 29 May 2026.

Advancing T2DM Management with Fixed Ratio Combination Therapy at CME by Sanofi, 29 May 2026.

Adult Vaccination at CME by GSK,IIHMR, 26 May 2026.

Lower LDL-C for Longer / Dapagliflozin Evidence at CME by Intas, 20 May 2026.

Foundations of Obesity Biology & Dual-Agonist Therapy at CME by Lilly, 13 May 2026.
Re-engineering Holistic Patient Care with Innovator Semaglutide at CME by Novo, 10 May 2026.

Health in wealth at ALL INDIA RADIO RADIO PINCK CITY, 6TH MAY.
The Changing Paradigm of Obesity Management at ASCEND Conclave 2.0, 3 May 2026.

Healthy Aging After 60 at RIC 2026, 25 April 2026.

Guest of Honour at JITO Ladies Wing, 14 April 2026.

Is Semaglutide Best in T2DM and Weight Reduction? at CME by MSN, 12 April 2026.

Real-World Power of Ozempic at CME by Novo, 10 April 2026.
Pro Chancellor & Sr. Professor at JNU, Jaipur
Professor Emeritus, SMS Medical College & Attached Group of Hospitals, Jaipur
MD, DNB, MNAMS, D.Sc (Hon. Causa)
FRCP (London), FRCP (Edinburgh)
FELLOW AMERICAN COLLEGE OF ENDOCRINOLOGY (FACE)
FELLOW AMERICAN COLLEGE OF PHYSICIANS (FACP)
FELLOW INDIAN COLLEGE OF PHYSICIANS (FICP)
FLLOW RESEARCH SOCIETY FOR THE STUDY OF
DIABETES IN INDIA (FRSSDI)